Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements
US12226375B1 · kind B1 · utility
0Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2024 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | May 21, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of agomelatine (or a prodrug or salt thereof) in the treatment of major depressive disorder or bipolar disorder, including the selection of patients who would most benefit from agomelatine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.